Gladius Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,794
| Closed | -$38.4K | – | 319 |
|
|
2024
Q1 | $38.4K | Buy |
+3,794
| New | +$38.4K | 0.01% | 174 |
|
|
2023
Q4 | – | Sell |
-2,111
| Closed | -$19.8K | – | 334 |
|
|
2023
Q3 | $19.8K | Buy |
+2,111
| New | +$19.8K | ﹤0.01% | 249 |
|
|
2023
Q2 | – | Sell |
-1,216
| Closed | -$28.3K | – | 391 |
|
|
2023
Q1 | $28.3K | Sell |
1,216
-148
| -11% | -$3.44K | ﹤0.01% | 212 |
|
|
2022
Q4 | $34.5K | Sell |
1,364
-165
| -11% | -$4.18K | ﹤0.01% | 232 |
|
|
2022
Q3 | $30K | Buy |
+1,529
| New | +$30K | ﹤0.01% | 251 |
|